(Total Views: 629)
Posted On: 11/11/2021 6:18:20 AM
Post# of 154916
Re: KenChowder #110312
Ken,
Announcement of submission of BLA was posted April 27, 2020.
Subsequent PR from May 11 noted submission of all remaining parts of BLA (data missing from original submission)
https://www.cytodyn.com/investors/news-events...pplication
https://www.cytodyn.com/investors/news-events...g-parts-of
Announcement of submission of BLA was posted April 27, 2020.
Subsequent PR from May 11 noted submission of all remaining parts of BLA (data missing from original submission)
Quote:
CytoDyn Submits Completed Biologics License Application (BLA) to the FDA for Leronlimab as a Combination Therapy for Highly Treatment Experienced HIV Patients
https://www.cytodyn.com/investors/news-events...pplication
Quote:
CytoDyn Completed Submission of All Remaining Parts of Biologics License Application (“BLA”) on May 11, 2020
https://www.cytodyn.com/investors/news-events...g-parts-of
(5)
(0)
